chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Redness, itching, swelling at and around injection site, tired and weak. This was at injection site of PREVNAR 13/not FLUZONE.
Body aches, chills, fever x2 days, nausea, headaches improving over 4 days
On April 7th in the  morning, I woke with sharp pain in right calf.  It was not swollen, discolored, or hot.  I had not participated in any activity recently that I felt caused an injury.  I took Advil and Tylenol and rested for a few days, but the pain got worse.  On April 14th, after reading reports on some adverse affects from the J&J vaccine, I made an appointment to see my primary physician.  After blood work and an ultrasound, I was diagnosed with a DVT in my right calf.  I have a started a 90-day cycle of Xarelto to treatment the DVT.
A report from VAERS concerns a 33 year old male. Medical history and concomitant medications were not reported. The patient received FLUMIST QUADRIVALENT (intranasal) and experienced ADEM. At the time of reporting, the outcome of the event was unknown. The reporter assessed the event to be serious as an important medical event. Based on the information in this report, and awaiting the reporter's assessment, the company physician considered the event to be at least possibly related to FLUMIST QUADRIVALENT. Corrected Report 12-Sep-2014: implied yes causality captured, solicited reporter deleted.
Approx. 12 minutes after vaccination, the patient reported to me with itching of the whole left arm,  what appears to be a red bump/whelp on the pt's outer chest, near left axillary area was present and  itchy.  With in a few minutes the pt's began to state that her throat was itchy and was progressing to feeling tight.  EMS was called @2:46pm, Benadryl 50mg orally administered @ 2:46 pm.  EMS arrived and evaluated the patient at 2:53 pm. Over time patient stated she began to feel better, her throat didn't feel as bad as it did initially.  The redness of her left arm and the whelp on her chest has began to look less aggravated, the redness had began to fade. The patient and her mother declined ER attention when offered by EMS and the staff here.  The EMS workers gave the patient and pt's mother instructions on what to do, EMS then departed at 3pm.  The staff here observed the patient until approximately around 3:10pm with furthered discharge instructions.
Two local assisted living residents presented with redness on lateral upper left arm 1-2 inches below the injection site. They were both taken to a local clinic for treatment. The first case was diagnosed with cellulitis and the second was under observation. This prompted the assisted living to examine the injection sites of all residents who received seasonal influenza vaccinations on 10/3/2018. Patient was found to have a 8 cm kidney shaped blotchy red area on the lateral upper left arm 1-2 inches below the injection site. He was advised to seek medical treatment but refused. Assisted living staff are monitoring the situation carefully.
4/1/21 - sore arm, slight fatigue 4/2/21 - muscle aches all over, fatigue - treated with OTC ibuprofen 4/3/21 - slight muscle aches, low-grade fever (99.9 F) - treated with OTC ibuprofen 4/4/21 - moderate presentation of rash/hives on lower inner arms, area between shoulders and chest, and base of spine  - treated with OTC benadryl, one dose in morning and one in evening
Patient's right foot went numb and was tingly on his drive home after receiving the vaccination.  He reported this to the pharmacy on 8/18/15.  He saw a doctor at the clinic on 8/20/15 and at that time stated his left foot was also feeling tingly and numb.  Provider ran labs and is ruling out Guillain-Barre syndrome and having patient follow up with neuropathy.
5 min after injection: radiating nerve pain down left arm.  5 hours after: sore LT upper arm and LT mid-rib cage.  Next morning 01/06: arm less sore, LT rib cage stabbing pain to take a deep breath; some RT rib cage tenderness; rib cage pain worse with prolonged sitting. Unable to lay flat or on sides. Only able to lay probe or with upper body elevated. Noticed congestion mainly at night and early morning. 01/07: arm tender; still experiencing some LT rib cage pain with deep breaths; still experiencing discomfort with laying flat on back or on sides. Congestion mild but noticed it during the day, as well. Everything tastes bland except spicy foods which were intolerable. Tested for COVID, both negative.  01/08: Woke up with chills and night sweats. LT rib cage tender, no problem with deep breaths. Left side of neck stiffness. Sudden onset of right side moderate sore throat/jaw pain/ear pain, happened within minutes. Congestion still present.
Dose #1...... very mild reaction nausea. Dose #2......more noticeable reaction with nausea/vomiting, shivering/chills, muscle aches.
High fever for 16 hours Severe joint pain  Shaking chills  Tachycardia and PVCs Hypertension  for 12hours  Dizziness Tiredness
11:14 am warm, flushing feeling head to toe. Thought it was "hot flash" since menopausal. Returned to work 12:10 swelling lips along with numbness. 12:20 itchy no visible rash. Vital signs stable throughout. No resp or oral difficultty. BENADRYL by mouth and SOLUMEDROL IM given. 12:55 reaction subsided.
Extremely red/swollen arm - radiated down arm could not bend arm full the first day (Sat - Sun). After taking BENADRYL he could bend at elbow fully (Tuesday).
This spontaneous report was received from a 66 year old male patient. On an unknown date in 2006, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date and dose unspecified), subcutaneously. No concomitant medications were reported. On 23-APR-2013, the patient was diagnosed with shingles outbreak red and swollen on his neck, on the right side under his ear. It was painful to his ear. The patient did not seek any medical attention. He was treated with acyclovir, a herpes viral inhibitor. It was unspecified if any lab tests were performed. The outcome of the events was unknown. The relatedness for the events was unknown for ZOSTAVAX. Additional information has been requested.
Left knee swelling off & on until Jan. Limping in Jan. Caused back problems in Feb/Mar. Went to a knee surgeon in Apr. Tried a cortisone shot. Lasted a month. Had knee surgery. Swelling persisted. Anti-inflammatory meds didn't work. Referred to the arthritis clinic (took 3 mo. to get appt.). Eventually diagnosed with reactive arthritis.
tenderness , soreness which moved to the middle area of the upper arm , an irregular patch; an irregular patch , a big red rash which is slightly itchy/itchy red rash; cold trickle; an irregular patch , a big red rash which is slightly itchy/itchy red rash; Swelling/slightly raised like bump and hard; needling Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash) and SWELLING (Swelling/slightly raised like bump and hard) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash), SWELLING (Swelling/slightly raised like bump and hard) and HEADACHE (needling Headache). At the time of the report, PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash), SWELLING (Swelling/slightly raised like bump and hard) and HEADACHE (needling Headache) outcome was unknown. Not Provided          Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No new information was provided on 22-APR-2021.
She was tested positive after the 1st dose; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 10Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced she was tested positive after the 1st dose. The caller (patient) called in to ask if she can still get the COVID-19 vaccine or she needs to reschedule because she received her 1st dose last 10Mar2021 and will get the 2nd dose on 31Mar2021. The seriousness of the event was reported as non-serious. The patient underwent lab tests and procedures which included SARS-COV-2 test: positive on an unspecified date. The clinical outcome of the event was unknown.   No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
purplish red in color, 2 to 4 inches in size on the same arm of injection site; Massive bruises (arm to breast); Sore arm (injection site); Arm pit was hurting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (purplish red in color, 2 to 4 inches in size on the same arm of injection site), CONTUSION (Massive bruises (arm to breast)), VACCINATION SITE PAIN (Sore arm (injection site)) and AXILLARY PAIN (Arm pit was hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced VACCINATION SITE PAIN (Sore arm (injection site)). 30-Aug-2021, the patient experienced AXILLARY PAIN (Arm pit was hurting). On 02-Sep-2021, the patient experienced CONTUSION (Massive bruises (arm to breast)). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (purplish red in color, 2 to 4 inches in size on the same arm of injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (purplish red in color, 2 to 4 inches in size on the same arm of injection site), CONTUSION (Massive bruises (arm to breast)), VACCINATION SITE PAIN (Sore arm (injection site)) and AXILLARY PAIN (Arm pit was hurting) outcome was unknown.            Relevant concomitant medications were not provided.  Reporter stated that the massive bruises are present on her left arm to breast which are purplish red in color, 2 to 4 inches in size.  reporter stated that she used ice pack.   Reporter did not allow further contact
Vaccine that was ordered was Gardasil 9, the vaccine that was documented as given had a MenQuadfi lot number. It is unknown if the HPV 9  was administered and mis-documented.
Flu-like Symptoms; aching; dizziness; nauseous; feeling hot; Shivering; muscle pain; joint pain; Welp great big welp near the injection site that is spreading; Vaccine Administered at Inappropriate Site; This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 3rd March 2019, refer case US2019108644).   On 13th June 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 13th June 2019, unknown after receiving Shingrix, the patient experienced vaccine administered at inappropriate site. On 14th June 2019, the patient experienced influenza-like symptoms, pain, dizziness, nausea, feeling hot, shivering, muscle pain, joint pain and injection site erythema. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms, pain, dizziness, nausea, feeling hot, shivering, muscle pain, joint pain and injection site erythema were recovered/resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the influenza-like symptoms, pain, dizziness, nausea, feeling hot, shivering, muscle pain, joint pain and injection site erythema to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient who herself was nurse. Yesterday from the date of reporting after 5 PM, the patient received 2nd dose on an unknown deltoid and experienced influenza-like symptoms, pain, dizziness, nausea, feeling hot, shivering, muscle pain, joint pain and injection site erythema. The symptoms were lasting just prior to the call after waking up on the day of reporting  The patient also observed great big welp, near the injection site that was spreading. The patient also mentioned that vaccine was administered between her shoulder and elbow and after probing, it was determined that the vaccine was administered below deltoid region, which led to vaccine administered at inappropriate site. The reporter did not consent to follow-up. This call was transferred to medical information (MI) for further queries and the patient wanted to know the efficacy of Shingrix if not administered in the deltoid.
Patient came in for 1st Moderna Covid vaccine. Patient filled out vaccine questionnaire form. Patient stated she has had no allergic reaction to another vaccine or injectable medication. Patient did state that she has allergic reactions to Wheat, corn, eggs, and nuts and does carry an epi pen. Patient stated she was nervous and did have anxiety problems. When going over paperwork with patient  nurse again asked patient is there were ANY medication allergies to which patient replied ?no?. Patient was instructed to wait for 30 minutes in her car after vaccine administration to be observed for any adverse reactions and to honk car horn should she need assistance. Patient agreed and vaccine was administered at 1305. Very shortly after, patient honked horn of car. Nurses went to car with wheelchair. Patient stated her lips were tingling and she felt like she was having anxiety. Patient assisted into WC. While patient was being wheeled back to east entrance, vaccine clinic staging area, patient stated that she was feeling nauseated and felt like vomiting. Patient then threw her head back, eyes closed and patient started to slide from the WC. Nurse assisted patient to the ground. Patient then started to seize and became unresponsive. 911 called at 1309, patient became responsive. First set of vitals taken at 1310. Privacy screen placed, tent canopy was moved over patient and team, linen placed on ground under patient to try and protect her from the hot pavement. Cooling measures taken. Second set of vitals taken at 1316. Patient verbal, alert, responsive, answering questions. Patient drank a small amount of water. Ambulance and fire arrived at 1320. Patient called mother on phone. Nurse secured patients car. Left in ambulance at 1338.
I had nausea and cold in morning. By afternoon got mild fever. I am sure I will recover, but just wanted to report for data keeping.
ACHES; SICK; UNABLE TO WORK; CHILLS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: UNKNOWN expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced chills, aches, unable to work, and sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, aches, and sick, and the outcome of unable to work was not reported. This report was non-serious.
Never took the 2nd dose, never will, pharmacist agrees; 1st dose CAUSED MY shingles within 2 days; Pain, suffered for nearly 3 weeks; This case was reported by a nurse via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles, pain and incomplete course of vaccination. The patient was treated with hydrocodone and calamine + zinc oxide (Calamine Lotion). On an unknown date, the outcome of the shingles and pain were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   The reporter considered the shingles to be related to Shingrix. It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingrix and experienced shingles within 2 days. The patient also experienced pain. The patient took Hydrocodone, used ice cold, wet wash cloths and Calamine lotion on them to ease the pain for nearly 3 weeks. The vaccine caused him/her shingles even though advertising sats it's a dead virus.  The patient stated Shingrix refused to compensate him/her the nearly $200 price as well as the doctor visited (to be diagnosed with shingles after he/she got the shot), pain medications etc. The patient advised against taking Shingrix. he/she was one of many who contracted Shingles from the 1st dose of it. The patient also stated that  it's a dead virus (supposedly) but his/her was apparently live and he/she suffered for nearly 3 weeks with it. The patient shall never take the 2nd dose and the pharmacist agreed he/she shouldn't. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR047714:Same reporter. Hearsay case.
12/13/21 and 12/15/21: pt tested positive for symptomatic COVID-19 via PCR tests 12/15/21: pt presents to ED with dyspnea and confirmed COVID-19 positive pt admitted pt treated with dexamethasone, remdesivir and tocilizumab - pt progressed to bipap 12/20/21: pt expired
Significant left supraclavicular and cervical lymphadenopathy; Supraclavicular lymphadenopathy; This is a spontaneous report received from a non-contactable physician, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 23Jan2021 (at the age of 38-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 23Feb2021, as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccine or any other medication within two weeks of the vaccination. On 06Feb021, the patient experienced significant left supraclavicular and cervical lymphadenopathy. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for the events left supraclavicular and cervical lymphadenopathy which included ultrasound and biopsy. The clinical outcome of the events left supraclavicular and cervical lymphadenopathy was resolved.  No follow-up attempts are possible. No further information is expected.
0650 Hepatitis B vaccine given IM, left anterior thigh. 0655 Color blue and apneic; stimulated to recovery. By 07/15, 3 more episodes of apnea requiring stimulation and oxygen. Doctor notified; antibiotics and IV started. Parents notified. The medical record received on 2/18/04 states the diagnosis was pyloric stenosis with pyloric spasm.
It was reported that a 42 year old male received Fluzone SV '00-'01 USP from his Employee Health on 12/7/00. Within several days, he had arthritic-like pain in his shoulder and joint where vaccine was given. The was also a round, raised rash. The doctor put him on Prednisone 6 day pack. Now, 1 month later, there is a scaly, psoriasis-looking rash that is bumpy and scabbed over and 1/2" in diameter.
Sore arm; slightly lightheaded; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 66-year-old non-pregnant female patient received a dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: En6199), via an unspecified route of administration on 03Mar2021 at 13:00 (at the age of 66-year-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation administered in facility. Medical history included known allergies from an unknown date and unknown if ongoing. Concomitant medications included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) inhaler taken for an unspecified indication, start and stop date were not reported, ascorbic acid, calcium carbonate, calcium pantothenate, calcium phosphate, chromium, cyanocobalamin, folic acid, magnesium carbonate, magnesium hydroxide, manganese gluconate, nicotinic acid, potassium bicarbonate, potassium carbonate, potassium phosphate dibasic, pyridoxine hydrochloride, quercetin, riboflavin sodium phosphate, sodium bicarbonate, sodium phosphate, thiamine hydrochloride, thioctic acid, zinc ascorbate (EMERGEN C) taken for an unspecified indication, start and stop date were not reported. It was reported that patient was not a pregnant at the time of vaccination. She did not take any other vaccine in four weeks prior COVID -19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 17:30 patient experienced sore arm, slightly lightheaded. No treatment was received for events. The outcome events was unknown.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. Pertinent medical history or drug allergies/drug reactions were not reported. On 24-MAR-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX (dose, route, lot number and expiration date were not provided). Concomitant medication was not provided. No adverse effect was reported. No product quality complaint (PQC) was involved. This is one of nine reports from the same reporter. Additional information has been requested.